PCM
SRGA

Prelude Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Prelude Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,099
Closed -$204K – 1920
2020
Q4 		$204K Buy
+3,099
New +$202K 0.01% 1111
2019
Q3 		– Sell
-99
Closed -$13K – 2205
2019
Q2 		$13K Buy
+99
New +$14.3K ﹤0.01% 1355
2017
Q4 		– Sell
-117
Closed -$16K – 1836
2017
Q3 		$16K Sell
117
-93
-44% -$14K ﹤0.01% 1362
2017
Q2 		$37K Sell
210
-369
-64% -$52.5K ﹤0.01% 1093
2017
Q1 		$69K Sell
579
-1,541
-73% -$160K 0.01% 900
2016
Q4 		$207K Buy
2,120
+524
+33% +$48K 0.03% 570
2016
Q3 		$150K Buy
1,596
+113
+8% +$11.3K 0.02% 662
2016
Q2 		$160K Sell
1,483
-538
-27% -$63K 0.02% 575
2016
Q1 		$243K Buy
2,021
+451
+29% +$47.4K 0.03% 485
2015
Q4 		$187K Buy
1,570
+500
+47% +$64.5K 0.03% 604
2015
Q3 		$182K Buy
1,070
+183
+21% +$35.1K 0.03% 632
2015
Q2 		$172K Sell
887
-16
-2% -$2.97K 0.02% 689
2015
Q1 		$134K Hold
903
– – 0.02% 868
2014
Q4 		$141K Buy
903
+700
+345% +$101K 0.02% 870
2014
Q3 		$29K Buy
+203
New +$29.4K ﹤0.01% 1660

Other funds holding SRGA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Prelude Capital Management's SRGA Position: Q1 2021 in Review

Prelude Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q1 2021, closing a stake of 3,099 shares — an estimated $204K sold.

Prelude Capital Management first reported a position in SRGA in Q3 2014 and held it in 15 quarters. The position peaked at $243K in Q1 2016. 105 funds tracked by Wall St. Rank hold SRGA as of Q1 2021.

  • Prelude Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Prelude Capital Management sold 3,099 Surgalign Holdings, Inc. Common Stock shares in Q1 2021, an estimated $204K.
  • Prelude Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2014 and held it in 15 quarters.
  • Prelude Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $243K in Q1 2016.
  • 105 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q1 2021.

Based on Prelude Capital Management's 13F filing for Q1 2021, filed 17 May 2021.